Skip to main content
SpringerLink
Log in

Pathophysiology of Fibromyalgia

  • Chapter
  • First Online:
Fibromyalgia

  • 2191 Accesses

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 39.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 54.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Ren K, Dubner R. Neuron-glia crosstalk gets serious: role in pain hypersensitivity. Curr Opin Ananes. 2008;21:570–9.

    Article  Google Scholar 

  2. Kim SH, Kim DH, Oh DH, Clauw DJ. Characteristic electron microscopic findings in the skin of patients with fibromyalgia: preliminary study. Clin Rheumatol. 2008;27:219–23.

    Article  PubMed  Google Scholar 

  3. Kim SH, Jang TJ, Moon IS. Increased expression of N-methyl-D-aspartate receptor subunit 2D in the skin of patients with fibromyalgia. J Rheumatol. 2006;33:785–8.

    PubMed  CAS  Google Scholar 

  4. Salemi S, Aeschlimann A, Wollina U, et al. Up-regulation of delta-opioid receptors and kappa-opioid receptors in the skin of fibromyalgia patients. Arthritis Rheum. 2007;56:2464–6.

    Article  PubMed  CAS  Google Scholar 

  5. Burgmer M, Gaubitz M, Konrad C, et al. Decreased gray matter volumes in the cingulo-frontal cortex and the amygdala in patients with fibromyalgia. Psychosom Med. 2009;71:566–73.

    Google Scholar 

  6. Moisset X, Bouhassira D, Denis D, et al. Anatomical connections between brain areas activated during rectal distension in healthy volunteers: A visceral pain network. Eur J Pain. 2010;14:142–8.

    Google Scholar 

  7. Wood PB, Glabus MF, Simpson R, Patterson JC. Changes in gray matter density in fibromyalgia: correlation with dopamine metabolism. J Pain. 2009;10:609–18.

    Google Scholar 

  8. Desmeules JA, Cedraschi C, Rapiti E, et al. Neurophysiologic evidence for a central sensitization in patients with fibromyalgia. Arthritis Rheum. 2003;48:1420–9.

    Article  PubMed  CAS  Google Scholar 

  9. Staud R, Vierck CJ, Cannon RL, Mauderli AP, Price DD. Abnormal sensitization and temporal summation of second pain (wind-up) in patients with fibromyalgia syndrome. Pain. 2001;91:165–75.

    Article  PubMed  CAS  Google Scholar 

  10. Gracely RH, Petzke F, Wolf JM, Clauw DJ. Functional magnetic resonance imaging evidence of augmented pain processing in fibromyalgia. Arthritis Rheum. 2002;46:1333–43.

    Article  PubMed  Google Scholar 

  11. Mainguy Y. Functional magnetic resonance imagery (fMRI) in fibromyalgia and the response to milnacipran. Hum Psychopharmacol. 2009;24:S19–23.

    Article  PubMed  Google Scholar 

  12. Bernstein C, Marcus DA. Fibromyalgia: current concepts in diagnosis, pathogenesis, and treatment. Pain Med News. 2008;6:8–19.

    Google Scholar 

  13. Wood PB. Role of central dopamine in pain and analgesia. Expert Rev Neurother. 2008;8:781–97.

    Article  PubMed  CAS  Google Scholar 

  14. Wood PB, Holman AJ. An elephant among us: the role of dopamine in the pathophysiology of fibromyalgia. J Rheumatol. 2009;36:221–4.

    Article  PubMed  Google Scholar 

  15. Holman AJ, Myers RR.A randomized, double-blind, placebo-controlled trial of pramipexole, a dopamine agonist, in patients with fibromyalgia receiving concomitant medications. Arthritis Rheum. 2005;52:2495–505.

    Article  PubMed  CAS  Google Scholar 

  16. Park JH, Niermann KJ, Olsen NJ. Evidence for metabolic abnormalities in the muscles of patients with fibromyalgia. Curr Rheumatol Rep. 2000;2:131–40.

    Article  PubMed  CAS  Google Scholar 

  17. Bazzichi L, Dini M, Rossi A, et al. Muscle modifications in fibromyalgia patients revealed by surface electromyography (SEMG) analysis. BMC Musculoskelet Disord. 2009;10:36.

    Article  PubMed  Google Scholar 

  18. Thompson J. Myofascial pain syndrome and fibromyalgia: a critical assessment and alternative view. Clin J Pain. 1998;14:82–4.

    Article  Google Scholar 

  19. Jegede AB, Gilbert C, Tulkin SR. Muscle characteristics of persons with fibromyalgia syndrome. Neurorehabilitation. 2008;23:217–30.

    PubMed  Google Scholar 

  20. Hubbard RD, Winkelstein BA. Transient cervical nerve root compression in the rat induces bilateral forepaw allodynia and spinal glial activation: mechanical factors in painful neck injuries. Spine. 2005;30:1924–32.

    Article  PubMed  Google Scholar 

  21. Holman AJ. Positional cervical spinal cord compression and fibromyalgia: a novel comorbidity with important diagnostic and treatment implications. J Pain. 2008;9:613–22.

    PubMed  Google Scholar 

  22. Heffez DS, Ross RE, Shade-Zeldow Y et al. Clinical evidence for cervical myelopathy due to Chiari malformation and spinal stenosis in a non-randomized group of patients with the diagnosis of fibromyalgia. Eur Spine J. 2004;13:516–23.

    Article  PubMed  Google Scholar 

  23. Heffez DS, Ross RE, Shade-Zeldow Y, et al. Treatment of cervical myelopathy in patients with the fibromyalgia syndrome: outcomes and implications. Eur Spine J. 2007;16:1423–33.

    Article  PubMed  Google Scholar 

  24. Jones KD, Deodhar P, Lorentzen A, Bennett RM, Deodhar AA. Growth hormone perturbations in fibromyalgia: a review. Semin Arthritis Rheum. 2007;36:357–79.

    Google Scholar 

  25. Bennett RM, Cook DM, Clark SR, Burckhardt CS, Campbell SM. Hypothalamic-pituitary-insulin-like growth factor-1 axis dysfunction in patients with fibromyalgia. J Rheumatol. 1997;24:1384–9.

    PubMed  CAS  Google Scholar 

  26. Paiva ES, Deodhar AA, Jones K, Bennett R. Impaired growth hormone secretion in fibromyalgia patients: Evidence for augmented hypothalamic somatostatin tone. Arthritis Rheum. 2002;46:1344–50.

    Article  PubMed  CAS  Google Scholar 

  27. Bennett RM, Clark SC, Walczyk J. A randomized, double-blind, placebo-controlled study of growth hormone in the treatment of fibromyalgia. Am J Med. 1998;104:227–31.

    Article  PubMed  CAS  Google Scholar 

  28. Valkeinen H, Häkkinen K, Pakarinen A, et al. Muscle hypertrophy, strength development, and serum hormones during strength training in elderly women with fibromyalgia. Scand J Rheumatol. 2005;34:309–14.

    Article  PubMed  CAS  Google Scholar 

  29. Jones KD, Deodhar AA, Burckhardt CS, et al. A combination of 6 months of treatment with pyridostigmine and triweekly exercise fails to improve insulin-like growth factor-I levels in fibromyalgia, despite improvement in the acute growth hormone response to exercise. J Rheumatol. 2007;34:1103–11.

    PubMed  CAS  Google Scholar 

  30. Jones KD, Burckhardt CS, Deodhar AA, et al. A six-month randomized controlled trial of exercise and pyridostigmine in the treatment of fibromyalgia. Arthritis Rheum. 2008;58:612–22.

    Article  PubMed  CAS  Google Scholar 

  31. Soy M, Guldiken S, Arikan E, Altun BU, Tuqrul A. Frequency of rheumatic diseases in patients with autoimmune thyroid disease. Rheumatol Int. 2007;27:575–7.

    Article  PubMed  Google Scholar 

  32. Bazzichi L, Rossi A, Giuliano T, et al. Association between thyroid autoimmunity and fibromyalgic disease severity. Clin Rheumatol. 2007;26:2115–20.

    Article  PubMed  Google Scholar 

  33. Pamuk ON, Cakir N. The frequency of thyroid antibodies in fibromyalgia patients and their relationship with symptoms. Clin Rheumatol. 2007;26:55–9.

    Article  PubMed  Google Scholar 

  34. Tanriverdi F, Karaca Z, Unluhizarci K, Kelestimur F. The hypothalamo-pituitary-adrenal axis in chronic fatigue syndrome and fibromyalgia syndrome. Stress. 2007;10:13–25.

    Article  PubMed  CAS  Google Scholar 

  35. Crofford LJ, Young EA, Engleberg NC, et al. Basal circadian and pulsatile ACTH and cortisol secretion in patients with fibromyalgia and/or chronic fatigue syndrome. Brain Behav Immun. 2004;18:314–25.

    Article  PubMed  CAS  Google Scholar 

  36. Crofford LJ. The hypothalamic-pituitary-adrenal stress axis in fibromyalgia and chronic fatigue syndrome. Z Rheumatol. 1998;57:67–71.

    Article  PubMed  Google Scholar 

  37. Schäfers M, Sorkin L. Effect of cytokines on neuronal excitability. Neurosci Lett. 2008;437:188–93.

    Article  PubMed  Google Scholar 

  38. Nair A, Bonneau RH. Stress-induced elevation of glucocorticoids increases microglia proliferation through NMDA receptor activation. J Neuroimmunology. 2006;171:72–85.

    Article  CAS  Google Scholar 

  39. Thompson ME, Barkhuizen A. Fibromyalgia, hepatitis C infection, and the cytokine connection.  Curr Pain Headache Rep. 2003;7:342–7.

    Article  PubMed  Google Scholar 

  40. Wang H, Buchner M, Moser MT, Daniel V, Schiltenwolf M. The role of IL-8 in patients with fibromyalgia: a prospective longitudinal study of 6 months. Clin J Pain. 2009;25:1–4.

    Article  PubMed  Google Scholar 

  41. Buskila D. Genetics of chronic pain states. Best Pract Res Clin Rheumatol. 2007;21:535–47.

    Article  PubMed  CAS  Google Scholar 

  42. Arnold LM, Hudson JI, Hess EV et al. Family study of fibromyalgia. Arthritis Rheum. 2004;50:944–52.

    Article  PubMed  Google Scholar 

  43. Kato K, Sullivan PF, Evengård B, Pederson NL. Importance of genetic influences on chronic widespread pain. Arthritis Rheum. 2006;54:1682–6.

    Article  PubMed  CAS  Google Scholar 

  44. Ablin JN, Cohen H, Buskila D. Mechanisms of disease: genetics of fibromyalgia. Nat Clin Pract Rheumatol. 2006;2:671–8.

    Article  PubMed  CAS  Google Scholar 

  45. Potvin S, Larouche A, Normand E, et al. DRD3 Ser9Gly polymorphism is related to thermal pain perception and modulation in chronic widespread pain patients and healthy controls. J Pain. 2009;10:969–75.

    Article  PubMed  CAS  Google Scholar 

  46. Bagis S, Tamer L, Sahin G, et al. Free radicals and antioxidants in primary fibromyalgia: an oxidative stress disorder? Rheumatol Int. 2005;25:188–90.

    Article  PubMed  CAS  Google Scholar 

  47. Altindag O, Celik H. Total antioxidant capacity and the severity of the pain in patients with fibromyalgia. Redox Rep. 2006;11:131–5.

    Article  PubMed  CAS  Google Scholar 

  48. Sukenik S, Abu-Shakra M, Flusser D. Physical trauma and fibromyalgia – is there a true association? Harefuah. 2008;147:712–6.

    PubMed  Google Scholar 

  49. Al-Allaf AW, Dunbar KL, Hallum NS, et al. A case-control study examining the role of physical trauma in the onset of fibromyalgia syndrome. Rheumatology. 2002;41:450–3.

    Article  PubMed  CAS  Google Scholar 

  50. Aaron LA, Bradley LA, Alarcón GS, et al. Perceived physical and emotional trauma as precipitating events in fibromyalgia. Associations with health care seeking and disability status but not pain severity. Arthritis Rheum. 1997;40:453–60.

    Article  PubMed  CAS  Google Scholar 

  51. Turk DC, Okifuji A, Starz TW, Sinclair JD. Effects of type of symptom onset on psychological distress in fibromyalgia syndrome patients. Pain. 1996;68:423–30.

    Article  PubMed  CAS  Google Scholar 

  52. Ruiz-Pérez I, Plazaola-Castaño J, Cáliz-Cáliz R, et al. Risk factors for fibromyalgia: the role of violence against women. Clin Rheumatol. 2009;28:777–86.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Anesthesiology, University of Pittsburgh, 3550 Terrace St., A-1305 Scaife Hall, Pittsburgh, Pennsylvania, 15261, USA

    Dawn A. Marcus

  2. Division of Arthritis & Rheumatic Diseases (OP09), Oregon Health & Science University, 3181 SW Sam Jackson Park Road, Portland, OR, 97239, USA

    Atul Deodhar MD

Authors
  1. Dawn A. Marcus
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Atul Deodhar MD
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Dawn A. Marcus .

Rights and permissions

Reprints and permissions

Copyright information

© 2011 Springer Science+Business Media, LLC

About this chapter

Cite this chapter

Marcus, D.A., Deodhar, A. (2011). Pathophysiology of Fibromyalgia. In: Fibromyalgia. Springer, New York, NY. https://doi.org/10.1007/978-1-4419-1609-9_3

Download citation

  • DOI: https://doi.org/10.1007/978-1-4419-1609-9_3

  • Published:

  • Publisher Name: Springer, New York, NY

  • Print ISBN: 978-1-4419-1608-2

  • Online ISBN: 978-1-4419-1609-9

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation